The Medical Letter on Drugs and Therapeutics
FROM
ISSUE1484
ISSUE1484
December 21, 2015
Intravenous Diclofenac (Dyloject)
Subscribers: Log in to read full article. Not a subscriber? Subscribe or purchase article. |
Intravenous Diclofenac (Dyloject)
December 21, 2015 (Issue: 1484)
The FDA has approved Dyloject (Hospira), an IV
formulation of the NSAID diclofenac sodium, for use
in adults. It can be administered alone for treatment
of mild to moderate pain or in combination with opioid
analgesics for moderate to severe...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.